Cargando…
Identification of druggable genes for multiple myeloma based on genomic information
Multiple myeloma (MM) is a hematological malignancy. It is widely believed that genetic factors play a significant role in the development of MM, as investigated in numerous studies. However, the application of genomic information for clinical purposes, including diagnostic and prognostic biomarkers...
Autores principales: | Satria, Rahmat Dani, Irham, Lalu Muhammad, Adikusuma, Wirawan, Puspitaningrum, Anisa Nova, Afief, Arief Rahman, Khair, Riat El, Septama, Abdi Wira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Genome Organization
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10584652/ https://www.ncbi.nlm.nih.gov/pubmed/37813627 http://dx.doi.org/10.5808/gi.23011 |
Ejemplares similares
-
Investigation of susceptibility genes for chickenpox disease across multiple continents
por: Irham, Lalu Muhammad, et al.
Publicado: (2022) -
Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
por: Afief, Arief Rahman, et al.
Publicado: (2022) -
Leveraging Genomic and Bioinformatic Analysis to Enhance Drug Repositioning for Dermatomyositis
por: Irham, Lalu Muhammad, et al.
Publicado: (2023) -
Transcriptomics-driven drug repositioning for the treatment of diabetic foot ulcer
por: Adikusuma, Wirawan, et al.
Publicado: (2023) -
A bioinformatic approach to identify pathogenic variants for Stevens-Johnson syndrome
por: Ma’ruf, Muhammad, et al.
Publicado: (2023)